Oppenheimer & Co’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,698
| Closed | -$346K | – | 1315 |
|
|
2019
Q2 | $346K | Sell |
7,698
-900
| -10% | -$40.5K | 0.01% | 951 |
|
|
2019
Q1 | $323K | Sell |
8,598
-3,500
| -29% | -$131K | 0.01% | 1008 |
|
|
2018
Q4 | $416K | Sell |
12,098
-2,500
| -17% | -$86K | 0.01% | 805 |
|
|
2018
Q3 | $686K | Sell |
14,598
-500
| -3% | -$23.5K | 0.02% | 735 |
|
|
2018
Q2 | $509K | Sell |
15,098
-1,900
| -11% | -$64.1K | 0.01% | 855 |
|
|
2018
Q1 | $460K | Sell |
16,998
-495
| -3% | -$13.4K | 0.01% | 884 |
|
|
2017
Q4 | $292K | Buy |
17,493
+2,400
| +16% | +$40.1K | 0.01% | 1067 |
|
|
2017
Q3 | $302K | Sell |
15,093
-27,500
| -65% | -$550K | 0.01% | 1033 |
|
|
2017
Q2 | $781K | Buy |
42,593
+18,273
| +75% | +$335K | 0.02% | 681 |
|
|
2017
Q1 | $239K | Sell |
24,320
-23,840
| -50% | -$234K | 0.01% | 1092 |
|
|
2016
Q4 | $525K | Sell |
48,160
-2,552
| -5% | -$27.8K | 0.02% | 792 |
|
|
2016
Q3 | $710K | Sell |
50,712
-36,744
| -42% | -$514K | 0.02% | 677 |
|
|
2016
Q2 | $613K | Buy |
87,456
+16,229
| +23% | +$114K | 0.02% | 716 |
|
|
2016
Q1 | $459K | Buy |
71,227
+12,636
| +22% | +$81.4K | 0.01% | 789 |
|
|
2015
Q4 | $1.9M | Buy |
58,591
+38,148
| +187% | +$1.24M | 0.06% | 363 |
|
|
2015
Q3 | $546K | Buy |
20,443
+3,136
| +18% | +$83.8K | 0.02% | 774 |
|
|
2015
Q2 | $833K | Buy |
17,307
+8,387
| +94% | +$404K | 0.02% | 686 |
|
|
2015
Q1 | $542K | Buy |
8,920
+4,320
| +94% | +$262K | 0.01% | 836 |
|
|
2014
Q4 | $238K | Sell |
4,600
-5,157
| -53% | -$267K | 0.01% | 1128 |
|
|
2014
Q3 | $429K | Buy |
+9,757
| New | +$429K | 0.01% | 912 |
|